During the past decade, Humanitas Centro Catanese Di Oncologia; Oncologia Medica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Humanitas Centro Catanese Di Oncologia; Oncologia Medica" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Consorzio Oncotech" with 1 trials sponsored, "IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy" with 1 trials sponsored and "Morphotek" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Humanitas Centro Catanese Di Oncologia; Oncologia Medica" #1 collaborator was "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Princess Margaret Hospital, Canada" with 1 trials as a collaborator, "San Giuseppe Moscati Hospital" with 1 trials as a collaborator and "University of Alberta" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Humanitas Centro Catanese Di Oncologia; Oncologia Medica" are "Breast Cancer" (2 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials), "Breast Neoplasm" (1 trials), "Breast Neoplasms" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Humanitas Centro Catanese Di Oncologia; Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Humanitas Centro Catanese Di Oncologia; Oncologia Medica" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Giredestrant" (2 trials), "LHRH Agonist" (2 trials), "Letrozole" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Humanitas Centro Catanese Di Oncologia; Oncologia Medica" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Humanitas Centro Catanese Di Oncologia; Oncologia Medica". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Humanitas Centro Catanese Di Oncologia; Oncologia Medica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Humanitas Centro Catanese Di Oncologia; Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Humanitas Centro Catanese Di Oncologia; Oncologia Medica has several departments that took part in Clinical trials: "Centro Catanese Di Oncologia; Oncologia Medica" - 7 trials